Molecular Landscaping of AML: Are we relearning the Past or Informing the Future?

Authors

Guido Marcucci, MD, Ohio State UniversityFollow

Document Type

Presentation

Presentation Date

10-8-2014

Abstract

Acute Myeloid Leukemia

• AML comprises several distinct entities that are genetically and epigenetically heterogeneous
• Cytogenetic and molecular heterogeneity is clinically relevant and has been used for risk-stratification, treatment selection and treatment guidance
• However, this approach lacks of the necessary accuracy.

Presentation: 54 minutes

Recommended Citation

Marcucci, MD, Guido, "Molecular Landscaping of AML: Are we relearning the Past or Informing the Future?" (2014). Kimmel Cancer Center Papers, Presentations, and Grand Rounds. Paper 17.
https://jdc.jefferson.edu/kimmelgrandrounds/17